Molecular imaging and biology · 2026
Deep Learning-based Synthesis of Amyloid PET Images from Structural MRI in Alzheimer's Disease.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Zongpai, Wu Jingpu, Wang Puyang, Chai Keyi, Jiang Shanshan, Onyike Chiadi U, Smith Gwenn S, Zhou Jinyuan, Alzheimer’s Disease Neuroimaging Initiative
Аннотация
RATIONALE: Amyloid-beta (Aβ) plaques in Alzheimer's disease (AD) are commonly imaged with specific PET radiotracers. To overcome the cost and availability limitations of PET, developing a more accessible diagnostic tool is essential. This study aimed to develop a deep-learning model that can synthesize Aβ-PET images from widely available MRI scans.
METHODS: The study utilized 431 subjects with both structural MRI and Aβ-PET scans from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, including 213 cognitively normal (CN), 180 mild cognitive impairment (MCI), and 38 AD dementia cases. A specialized Vector Quantized Generative Adversarial Network (VQGAN) framework has been trained to generate Aβ-PET images from MRI features, utilizing datasets from patients across various stages of AD spectrum. A paired t-test was used to compare synthetic and real Aβ-PET scans, while an ANOVA was performed to evaluate standardized uptake value ratio differences among the CN, MCI, and AD dementia groups.
RESULTS: The synthesized Aβ-PET images closely resemble real Aβ-PET scans in terms of regional Aβ distribution, accurately capturing disease-stage characteristics across the AD spectrum. In three key cortical brain regions (frontal cortex, lateral temporal lobe, and posterior cingulate cortex and precuneus), the synthetic images have successfully replicated disease-related Aβ trends, showing statistically significant group differences (p < 0.05). Quantitative evaluation has confirmed the superiority of VQGAN over other models (lower MAE, higher PSNR/SSIM), demonstrating minimized errors, reduced noise, and better structural fidelity in synthesized images.
CONCLUSION: This technology potentially offers a cost-effective, non-invasive alternative method for AD diagnosis and staging.
METHODS: The study utilized 431 subjects with both structural MRI and Aβ-PET scans from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, including 213 cognitively normal (CN), 180 mild cognitive impairment (MCI), and 38 AD dementia cases. A specialized Vector Quantized Generative Adversarial Network (VQGAN) framework has been trained to generate Aβ-PET images from MRI features, utilizing datasets from patients across various stages of AD spectrum. A paired t-test was used to compare synthetic and real Aβ-PET scans, while an ANOVA was performed to evaluate standardized uptake value ratio differences among the CN, MCI, and AD dementia groups.
RESULTS: The synthesized Aβ-PET images closely resemble real Aβ-PET scans in terms of regional Aβ distribution, accurately capturing disease-stage characteristics across the AD spectrum. In three key cortical brain regions (frontal cortex, lateral temporal lobe, and posterior cingulate cortex and precuneus), the synthetic images have successfully replicated disease-related Aβ trends, showing statistically significant group differences (p < 0.05). Quantitative evaluation has confirmed the superiority of VQGAN over other models (lower MAE, higher PSNR/SSIM), demonstrating minimized errors, reduced noise, and better structural fidelity in synthesized images.
CONCLUSION: This technology potentially offers a cost-effective, non-invasive alternative method for AD diagnosis and staging.